Three Bridge Wealth Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SVCM
Three Bridge Wealth Advisors's AMLX Position: Q3 2026 in Review
Three Bridge Wealth Advisors opened a new position in Amylyx Pharmaceuticals (AMLX) in Q3 2026: 6,666 shares worth $194K. The stake represents 0.04% of the portfolio and ranks #95 among its holdings.
230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- Three Bridge Wealth Advisors held 6,666 shares of Amylyx Pharmaceuticals worth $194K as of Q3 2026.
- Amylyx Pharmaceuticals was a new Three Bridge Wealth Advisors position in Q3 2026.
- Amylyx Pharmaceuticals made up 0.04% of Three Bridge Wealth Advisors's portfolio in Q3 2026, its #95 holding.
- 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on Three Bridge Wealth Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.